Akouos Inc

NASDAQ:AKUS  
20.56
+1.20 (+6.20%)
Earnings Announcements

Akouos Reports Third Quarter 2020 Financial Results And Provides Business Highlights

Published: 11/12/2020 12:23 GMT
(AKUS) - Akouos Reports Third Quarter 2020 Financial Results and Provides Business Highlights.
Q3 Loss per Share $0.85.
Q3 Earnings per Share Estimate $-0.39 -- Refinitiv Ibes Data (analyst estimates).
Plans to Submit an Ind Application to FDA in 2021 to Conduct a Phase 1/2 Clinical Trial.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.46

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.44

More details on our Analysts Page.